Medicine
Paxlovid kit
Paxlovid kit is a prescription medicine containing Nirmatrelvir and Ritonavir, marketed by Pfizer Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at USP controlled room temperature 20°C to 25°C (68°F to 77°F)…
Key facts
- Active ingredient (INN)
- Nirmatrelvir and Ritonavir
- Brand
- Paxlovid
- Dosage form
- Kit
- Packs
- 10 blister pack, 1 blister pack and 2 more
- Marketing authorisation holder
- Pfizer Laboratories
- Manufacturer
- Pfizer Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at USP controlled room temperature 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AE30 Nirmatrelvir and Ritonavir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 October 2023
- Identifiers
- RxCUI 900575, 2587897, 2587898 +5DailyMed set ID 8a99d6d6-fd9e-45bb-b1bf-48c7f761232aNDC 0069-5317, 0069-5321, 0069-5434 +2Application NDA217188
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 blister pack in 1 carton / 1 kit in 1 blister pack * 2 tablet, film coated in 1 blister pack * 1 tablet, film coated in 1 blister pack | 0069-5045-30 | Pfizer Laboratories | 9 July 2025 |
| 10 blister pack in 1 carton / 1 kit in 1 blister pack * 1 tablet, film coated in 1 blister pack * 1 tablet, film coated in 1 blister pack | 0069-5317-20 | Pfizer Laboratories | 18 October 2023 |
| 10 blister pack in 1 carton / 1 kit in 1 blister pack * 2 tablet, film coated in 1 blister pack * 1 tablet, film coated in 1 blister pack | 0069-5321-30 | Pfizer Laboratories | 18 October 2023 |
| 10 blister pack in 1 carton / 1 kit in 1 blister pack * 1 tablet, film coated in 1 blister pack * 1 tablet, film coated in 1 blister pack | 0069-5434-20 | Pfizer Laboratories | 9 July 2025 |
| 1 blister pack in 1 carton / 1 kit in 1 blister pack * 6 tablet, film coated in 1 blister pack * 5 tablet, film coated in 1 blister pack | 0069-5450-11 | Pfizer Laboratories | 5 January 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Nirmatrelvir and Ritonavir is a fixed-dose combination medicine indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19, including hospitalization or death. MedsAcross supplies Nirmatrelvir and Ritonavir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Nirmatrelvir and RitonavirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Paxlovid prescribing information (Pfizer Laboratories) · U.S. National Library of Medicine, DailyMed
- Paxlovid: European public assessment report (EPAR) · European Medicines Agency
Need Paxlovid kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.